How to wean off tirzepatide: 6 tips for tapering

6 min read

Written by: 

Amelia Willson

Reviewed by: 

Joanna Jan, MD

Updated:  Jul 29, 2026

Trusted source badge

Reviewed By

Joanna Jan, MD

Joanna Jan, MD, is a board-certified internal medicine physician, medical writer, and medical reviewer with over a decade of experience in clinical medicine, medical education, and evidence-based health communication.

View bio

Key takeaways

  • Weaning off tirzepatide should be done under the care and guidance of a healthcare provider. 

  • Side effects should subside soon after weaning off tirzepatide, but weight gain is common as appetite and cravings return. 

  • Successful strategies for maintaining weight loss after stopping tirzepatide include following a low-calorie diet, increasing exercise intensity and duration, and weight tracking.

Here's what we'll cover

Here's what we'll cover

Key takeaways

  • Weaning off tirzepatide should be done under the care and guidance of a healthcare provider. 

  • Side effects should subside soon after weaning off tirzepatide, but weight gain is common as appetite and cravings return. 

  • Successful strategies for maintaining weight loss after stopping tirzepatide include following a low-calorie diet, increasing exercise intensity and duration, and weight tracking.

While GLP-1s such as tirzepatide are meant to be long-term treatments for obesity and type 2 diabetes (among other conditions), there are situations where you may want to stop taking the medication.  Maybe the side effects have become too much, you’re planning to get pregnant, or you’ve met your weight loss goals

Whatever your reasons, this guide explains how to wean off tirzepatide safely, what to consider when doing so, and how to maintain your weight loss afterward.

How to wean off tirzepatide: 6 strategies

First things first: Weaning off tirzepatide should only be done under the care and guidance of a licensed healthcare provider. That said, here’s what you can expect from the process.

1. Talk to your healthcare provider 

If you’re considering stopping tirzepatide, your first step should be to contact your healthcare provider. Tell them why you want to taper off tirzepatide, as their recommendations may vary depending on the reason. And in some cases, there may be other things you can try before stopping cold turkey (which you should never do anyway). 

Here are some common reasons for stopping tirzepatide and potential solutions:

  • High cost: This is one of the top reasons people consider stopping tirzepatide, but there may be ways you can lower the cost of Mounjaro or Zepbound — even without insurance. Cash payers can get Zepbound on Ro for the lowest prices available, while those with insurance may be eligible for Eli Lilly’s manufacturer savings offers. 

  • Bothersome side effects: It’s also common for people to want to wean off tirzepatide due to the drug’s gastrointestinal side effects. But these side effects are often dose-dependent, so your healthcare provider may first try lowering your dose to see if that improves things before helping you taper off tirzepatide.

  • Pregnancy or breastfeeding: Tirzepatide should not be taken during pregnancy, as it may cause harm to the fetus. Ideally, the drug should be stopped before you get pregnant, so if you’re planning to conceive, tell your healthcare provider.

  • Achieved weight loss goals: Some people want to wean off tirzepatide once they’ve met a certain weight loss milestone, even though the drug also helps with weight maintenance. In this scenario, your healthcare provider may warn you about the risks of weight regain (more on this later) and offer guidance for keeping the weight off.

If you decide that you still want to stop tirzepatide, your healthcare provider will explain how to do so safely. It may be possible to simply stop with your last dose, as the drug’s five-day half-life provides a natural taper as it washes out of your system in a few weeks. 

Important: In rare cases, tirzepatide can cause serious side effects that require immediate medical attention. If you experience any of the following, seek emergency medical treatment and stop taking tirzepatide:

  • Severe stomach pain (sometimes moving to your back), nausea, vomiting, or diarrhea that does not go away

  • Signs of a serious allergic reaction (e.g. swelling of the face, lips, tongue, or throat; trouble breathing or swallowing; severe rash or itching; rapid heartbeat; or fainting)

  • Signs of gallbladder problems (e.g. pain in the upper stomach, yellowing of the skin or eyes, fever, and clay-colored poop)

2. Update your treatment plan

Once you (along with your healthcare provider) have decided to wean off tirzepatide, your provider may adjust your treatment plan. This can look different depending on what you were taking tirzepatide for.

  • Type 2 diabetes: Your healthcare provider may adjust the dosage of your other medications — such as metformin, insulin, or sulfonylureas — to help keep your blood sugar levels under control. They may also recommend an alternate diabetes medication, and recommend monitoring your blood sugar more often as you wean off tirzepatide. 

3. Keep up with exercise 

People who started exercising during GLP-1 treatment (and continued doing so after stopping treatment) tend to regain less weight than people who don’t, according to research.

In general, several studies have found that exercise can be a powerful tool for long-term weight management. It supports a healthy metabolism. Plus, exercise can also help maintain the improvements in blood pressure, cholesterol, and blood sugar levels you may have experienced on tirzepatide. 

For weight loss maintenance, the research supports:

  • 200–300 minutes per week of moderate- or high-intensity aerobic exercise.

  • At least two strength training workouts per week

Resistance exercise can help maintain the muscles you built on tirzepatide and prevent your metabolism from slowing down.

4. Focus on filling foods

You may have already made significant changes to your diet while taking tirzepatide. Now that you’re tapering off the medication, it’s important to keep up those healthy habits — although you may want to make some minor adjustments.

Specifically, you may want to focus on foods that are more filling but lower in calories. Typically, this translates to high-fiber or high-protein foods, such as:

  • Nuts

  • Low-fat yogurt

  • Eggs

  • Legumes

  • Fruits and veggies with the skin on (especially prunes)

  • Popcorn

  • Oats

5. Track your weight

By regularly tracking your weight, you’re better positioned to take action if you see it ticking back up. Plus, studies show that people who continue tracking their weight post-weight loss are more successful at keeping the weight off.  The key is to track often and consistently. 

For example, if you count your calories, you may be more successful if you track them for each meal and do your best not to skip a day of tracking. In one study, people lost more weight in the weeks that they did more tracking.

Find your recommended calorie deficit

A calorie deficit happens when you consume fewer calories than you burn. It’s key to weight loss and can help guide your nutrition strategy. Use the tool below to estimate how many calories you need each day to reach your weight loss goals safely.

Maintain your current weight

----

cal daily

Lose one pound per week

----

cal daily

Time to achieve your __ goal weight

----

Weeks

This calculator is for informational purposes only and not a substitute for medical advice. Individual needs vary. Consult a healthcare provider before making changes. Eating fewer than 1,200 (women) or 1,500 (men) calories a day is not recommended.

6. Schedule a follow-up appointment

Finally, it’s a good idea to schedule a follow-up appointment with your healthcare provider. They may recommend testing to monitor changes in your blood sugar, cholesterol, and blood pressure since stopping tirzepatide.

What happens when you stop tirzepatide?

What can you expect after stopping tirzepatide? Generally, people experience the following:

  • Weight regain: When you stop Mounjaro or Zepbound, the effects of the drug also stop. That means your appetite, hunger, “food noise,” and cravings may all return. As a result, people may regain roughly two-thirds of the weight they lost in the first year after stopping tirzepatide.

  • Reduced glycemic control: If you were taking tirzepatide to treat your type 2 diabetes, your HbA1c levels may also increase. To prevent this from happening, your healthcare provider may recommend continuing to manage your diabetes with other medications.

  • Other metabolic changes: Studies of tirzepatide show that it can lower blood pressure and cholesterol. These improvements may also reverse when you stop taking tirzepatide, particularly if you experience weight gain.

  • Mental health: It can be frustrating and disappointing to experience these changes.  In addition, poor mental health can make it harder to keep up with healthy habits after stopping tirzepatide. 

  • Side effects: In this long list of negatives, there is one positive to stopping tirzepatide: no more side effects. As the drug flushes out of your system, so should any nausea, diarrhea, vomiting, or other symptoms that were troubling you on tirzepatide.

How to maintain weight loss after stopping tirzepatide

Some amount of weight regain is common after stopping tirzepatide. However, there are several steps you can take to maintain weight loss. The following weight maintenance techniques are all backed by research.

1. Maintain a low-calorie diet. Low-calorie diets can help you lose weight and keep it off. Increasing your protein and fiber intake can help you combat any cravings that return after stopping tirzepatide. Fiber and protein both help you feel fuller, while protein helps you maintain muscle mass and a strong metabolism.

2. Reach for healthy snacks. Good options include popcorn (without butter), nuts, or a cup of low-fat yogurt. Vegetables, whole grains, and legumes can help you eat fewer calories without feeling as hungry. 

3. Manage your eating habits and patterns. In addition to what you eat, pay attention to when you eat. Avoid going too long between meals, and try to eat smaller portions regularly throughout the day — on a consistent schedule if possible. Eat heavier meals earlier in the day, and avoid eating too close to bedtime

4. Ramp up the exercise. The standard recommendation for aerobic exercise is 150 minutes per week. But research shows that to keep the weight off, you need to aim for 300 minutes weekly. Choose moderate- to high-intensity workouts like running, dancing, or cycling, and add in another strength training workout for good measure. 

5. Track your weight. Tracking helps you stay accountable. In addition to tracking your weight, consider tracking your daily calorie intake and workout regimen. If your weight starts to increase, you can get ahead of it early by changing up your diet or talking to your provider about starting weight loss medication again. 

6. Get a good night’s sleep. Poor sleep is consistently linked to increased calorie intake and a slower metabolism. Aim for 7–9 hours of uninterrupted sleep nightly to maintain a healthy weight after stopping tirzepatide.

7. Work with a professional. Various professionals are trained in developing personalized plans for helping people lose weight and keep it off, including healthcare providers, dietitians, physical trainers, and even therapists. In particular, studies show that cognitive behavioral therapy (CBT) can be effective for long-term weight maintenance.

Fastest-working GLP-1 for faster weight loss

Bottom line

People may wean off tirzepatide for a variety of reasons, from side effects and cost to pregnancy. If you find yourself in this situation, here’s what to remember:

  • Consulting your healthcare provider should be your first step. They can guide you on how to taper off your dose and recommend other options before stopping, such as trying a lower maintenance dose.

  • Expect some weight gain as your appetite and cravings return. Blood sugar levels, cholesterol, and blood pressure may also increase when stopping tirzepatide.

  • Low-calorie yet filling foods are key to success. Foods that are high in protein and fiber will keep you fuller longer, so it’s easier to stick to a low-calorie diet.

  • Set a goal to squeeze in 300 minutes of aerobic exercise weekly. Dedicate at least two workouts to strength training exercises.

  • Track your weight. Weight tracking can keep you accountable and help you make changes sooner rather than later if needed.

Frequently asked questions (FAQs)

DISCLAIMER

If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.

GLP-1 Important Safety Information: Read more about serious warnings and safety info.

Mounjaro Important Safety Information: Read more about serious warnings and safety info.

Zepbound Important Safety Information: Read more about serious warnings and safety info.

References

  • Alyafei, A., Balfour, J., & Keyes, D. (2025). Physical activity and weight loss maintenance. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK572051/

  • Aronne, L. J., Sattar, N., Horn, D. B., et al. (2023). Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity. JAMA, 331(1), 38. doi: 10.1001/jama.2023.24945. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10714284/

  • Budini, B., Luo, S., Tam, M., et al. (2026). Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression. EClinicalMedicine, 93, 103796. doi: 10.1016/j.eclinm.2026.103796. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC13043475/

  • Cengiz, A., Wu, C. C., & Lawley, S. D. (2025). Alternative dosing regimens of GLP ‐1 receptor agonists may reduce costs and maintain weight loss efficacy. Diabetes Obesity and Metabolism, 27(4), 2251–2258. doi: 10.1111/dom.16229. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11885104/

  • Fredrick, T., Camilleri, M., & Acosta, A. (2025). Pharmacotherapy for Obesity: recent updates. Clinical Pharmacology Advances and Applications, 17, 305–327. doi: 10.2147/cpaa.s497904. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12456317/

  • Gasoyan, H., Butsch, W. S., Casacchia, N. J., et al. (2025). Reasons for discontinuation of obesity pharmacotherapy with semaglutide or tirzepatide in clinical practice. Obesity, 33(12), 2296–2303. doi: 10.1002/oby.70058. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12636059/

  • Gasoyan, H., Schulte, R., Boyer, C. B., et al. (2026). Obesity treatments and weight changes in clinical practice after discontinuation of semaglutide or tirzepatide. Diabetes Obesity and Metabolism, 28(6), 4795–4805. doi: 10.1111/dom.70660. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC13146129/

  • Hall, K. D. & Kahan, S. (2017). Maintenance of lost weight and Long-Term management of obesity. Medical Clinics of North America, 102(1), 183–197. doi: 10.1016/j.mcna.2017.08.012. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC5764193/

  • Horn, D. B., Linetzky, B., Davies, M. J., et al. (2025). Cardiometabolic parameter change by weight regain on tirzepatide withdrawal in adults with obesity. JAMA Internal Medicine, 186(2), 157. doi: 10.1001/jamainternmed.2025.6112. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12645400/

  • Jayedi, A., Soltani, S., Emadi, A., et al. (2024). Aerobic exercise and weight loss in adults. JAMA Network Open, 7(12), e2452185. doi: 10.1001/jamanetworkopen.2024.52185. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11672165/

  • Madjd, A., Taylor, M. A., Delavari, A., et al. (2019). Effects of cognitive behavioral therapy on weight maintenance after successful weight loss in women; a randomized clinical trial. European Journal of Clinical Nutrition, 74(3), 436–444. doi: 10.1038/s41430-019-0495-9. Retrieved from https://pubmed.ncbi.nlm.nih.gov/31462695/

  • Manoogian, E. N. C., Chaix, A., & Panda, S. (2019). When to Eat: The importance of eating patterns in health and disease. Journal of Biological Rhythms, 34(6), 579–581. doi: 10.1177/0748730419892105. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7213043/

  • Miketinas, D. C., Bray, G. A., Beyl, R. A., et al. (2019). Fiber intake predicts weight loss and dietary adherence in adults consuming Calorie-Restricted Diets: the POUNDS Lost (Preventing Overweight Using Novel Dietary Strategies) study. Journal of Nutrition, 149(10), 1742–1748. doi: 10.1093/jn/nxz117. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6768815/

  • Moon, J. & Koh, G. (2020). Clinical Evidence and Mechanisms of High-Protein Diet-Induced Weight Loss. Journal of Obesity & Metabolic Syndrome, 29(3), 166–173. doi: 10.7570/jomes20028. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7539343/

  • Njike, V. Y., Smith, T. M., Shuval, O., et al. (2016). Snack Food, Satiety, and Weight. Advances in Nutrition (Bethesda, Md.), 7(5), 866–878. doi: 10.3945/an.115.009340. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC5015032/

  • Papatriantafyllou, E., Efthymiou, D., Zoumbaneas, E., et al. (2022). Sleep deprivation: Effects on weight loss and weight loss maintenance. Nutrients, 14(8), 1549. doi: 10.3390/nu14081549. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9031614/

  • Peterson, N. D., Middleton, K. R., Nackers, L. M., et al. (2014). Dietary self‐monitoring and long‐term success with weight management. Obesity, 22(9), 1962–1967. doi: 10.1002/oby.20807. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC4149603/

  • Rebello, C., Greenway, F. L., & Dhurandhar, N. V. (2014). Functional foods to promote weight loss and satiety. Current Opinion in Clinical Nutrition & Metabolic Care, 17(6), 596–604. doi: 10.1097/mco.0000000000000110. Retrieved from https://pubmed.ncbi.nlm.nih.gov/25159561/

  • Reiss, A. B., Gulkarov, S., Lau, R., et al. (2025). Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss. Biomolecules, 15(3), 408. doi: 10.3390/biom15030408. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11940170/

  • Rodriguez, P. J., Zhang, V., Gratzl, S., et al. (2025). Discontinuation and reinitiation of Dual-Labeled GLP-1 receptor agonists among US adults with overweight or obesity. JAMA Network Open, 8(1), e2457349. doi: 10.1001/jamanetworkopen.2024.57349. Retrieved from https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2829779

  • U.S. Food and Drug Administration (FDA-a). (2026). Highlights of Prescribing Information: Mounjaro (tirzepatide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215866s009lbl.pdf

  • U.S. Food and Drug Administration (FDA-b). (2026). Highlights of Prescribing Information: Zepbound (tirzepatide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s042lbl.pdf

  • West, S., Scragg, J., Aveyard, P., et al. (2026). Weight regain after cessation of medication for weight management: systematic review and meta-analysis. BMJ, 392, e085304. doi: 10.1136/bmj-2025-085304. Retrieved from https://www.bmj.com/content/392/bmj-2025-085304

  • Wu, H., Yang, W., Guo, T., et al. (2025). Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications. BMC Medicine, 23(1), 398. doi: 10.1186/s12916-025-04200-0. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12281790/

  • Żurawski, T. & Bartosiewicz, A. (2025). Dietary and Behavioral Strategies for Weight loss and Weight loss Maintenance: A Narrative review. Nutrients, 18(1), 12. doi: 10.3390/nu18010012. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12787890/

get help finding insurance coverage for weight loss medication

Our insurance concierge partners will work to find you coverage for medication.

Here's how they'll do it: